SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+4.59%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$624M
AUM Growth
+$624M
(+12%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
33.26%
Holding
155
New
31
Increased
26
Reduced
30
Closed
22
Top Buys
| 1 |
Viatris
VTRS
|
$32M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$9.79M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.74M |
| 5 |
Viking Therapeutics
VKTX
|
$7.53M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$18.6M |
| 2 |
Biogen
BIIB
|
$9.81M |
| 3 |
Ituran Location and Control
ITRN
|
$8.27M |
| 4 |
ORBK
Orbotech Ltd
ORBK
|
$6.62M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$5.33M |
Sector Composition
| 1 | Healthcare | 80.48% |
| 2 | Technology | 4.94% |
| 3 | Communication Services | 3.07% |
| 4 | Financials | 1.38% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHXM
76
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $2.64M | 0.31% | +120,000 | New | +$2.64M |
|
77
MacroGenics
MGNX
$112M
| $2.64M | 0.31% | 138,700 -70,000 | -34% | -$1.33M |
|
|
CASC
78
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $2.52M | 0.3% | 681,210 | – | – |
|
79
Summit Therapeutics
SMMT
$17.6B
| $2.35M | 0.28% | 212,018 | – | – |
|
80
Palo Alto Networks
PANW
$127B
| $2.33M | 0.27% | 16,055 -4,750 | -23% | -$688K |
|
81
Corvus Pharmaceuticals
CRVS
$428M
| $2.29M | 0.27% | 221,430 | – | – |
|
82
Ardelyx
ARDX
$1.53B
| $2.28M | 0.27% | 345,000 | – | – |
|
83
Catalyst Pharmaceutical
CPRX
$2.52B
| $2.26M | 0.26% | +576,825 | New | +$2.26M |
|
|
84
Teva Pharmaceuticals
TEVA
$21.1B
| $2.25M | 0.26% | 118,750 -281,250 | -70% | -$5.33M |
|
85
Cartesian Therapeutics
RNAC
$261M
| $2.24M | 0.26% | 228,534 | – | – |
|
|
CTIC
86
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.23M | 0.26% | 833,633 | – | – |
|
|
CBAY
87
DELISTED
Cymabay Therapeutics
CBAY
| $2.21M | 0.26% | +240,000 | New | +$2.21M |
|
|
ORBK
88
DELISTED
Orbotech Ltd
ORBK
| $2.19M | 0.26% | 43,488 -131,755 | -75% | -$6.62M |
|
89
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.18M | 0.26% | 248,472 | – | – |
|
90
Galmed Pharmaceuticals
GLMD
$6.96M
| $2.16M | 0.25% | +238,095 | New | +$2.16M |
|
|
SRRA
91
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.05M | 0.24% | +550,000 | New | +$2.05M |
|
92
Comcast
CMCSA
$125B
| $1.88M | 0.22% | 46,905 -19,455 | -29% | -$779K |
|
93
KALA BIO
KALA
$78.8M
| $1.85M | 0.22% | +100,000 | New | +$1.85M |
|
94
Ovid Therapeutics
OVID
$91M
| $1.78M | 0.21% | 180,674 -125,000 | -41% | -$1.23M |
|
95
Mastercard
MA
$538B
| $1.74M | 0.2% | 11,525 | – | – |
|
96
Evoke Pharma
EVOK
$8.49M
| $1.74M | 0.2% | 769,149 +198,127 | +35% | +$448K |
|
|
NEOS
97
DELISTED
Neos Therapeutics, Inc
NEOS
| $1.73M | 0.2% | +170,032 | New | +$1.73M |
|
98
Cytokinetics
CYTK
$4.23B
| $1.71M | 0.2% | 210,000 -17,990 | -8% | -$147K |
|
99
ProQR Therapeutics
PRQR
$237M
| $1.71M | 0.2% | 530,000 | – | – |
|
100
vTv Therapeutics
VTVT
| $1.69M | 0.2% | 281,679 -18,321 | -6% | -$110K |
|